Vista Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE427C01021
  • NSEID:
  • BSEID: 524711
INR
6.25
0.1 (1.63%)
BSENSE

Nov 20

BSE+NSE Vol: 17.07 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 384463,
    "name": "Vista Pharma.",
    "stock_name": "Vista Pharma.",
    "full_name": "Vista Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/vista-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "6.25",
    "chg": 0.1,
    "chgp": "1.63%",
    "dir": 1,
    "prev_price": "6.15",
    "mcapval": "40.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524711,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE427C01021",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "17.07 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/vista-pharma-384463-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-4243070",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/VistaPharmaceut_mojoScore_4243070.png",
        "date": "2026-10-29 10:10:55",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 July 2024. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 29 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-4211104",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/VistaPharmaceut_mojoScore_4211104.png",
        "date": "2026-10-01 10:10:27",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 July 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 October 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Vista Pharmaceuticals Ltd Falls to 52-Week Low of Rs 5.5 as Sell-Off Deepens",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/vista-pharmaceuticals-ltd-stock-falls-to-52-week-low-of-rs55-4186820",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/VistaPharmaceut_priceRelatedfactors_4186820.png",
        "date": "2026-09-08 14:45:14",
        "description": "For the second consecutive session, Vista Pharmaceuticals Ltd has seen its share price decline, hitting a fresh 52-week low of Rs 5.5 on 8 Sep 2026. This latest drop extends the stock’s downward trajectory, which has now resulted in a 5.41% loss over just two days, underscoring persistent selling pressure amid broader market weakness."
      },
      {
        "title": "Vista Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/vista-pharmaceuticals-ltd-is-rated-strong-sell-4171508",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/VistaPharmaceut_mojoScore_4171508.png",
        "date": "2026-08-27 10:10:22",
        "description": "Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 July 2024. However, the analysis and financial metrics discussed below reflect the company’s current position as of 27 August 2026, providing investors with the latest insights into the stock’s performance and outlook."
      }
    ],
    "total": 21,
    "sid": "384463",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/vista-pharmaceuticals-384463"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
      "datetime": "12-Sep-2026",
      "details": "Resignation of Company Secretary & Compliance Officer",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Results For The Quarter Ended 30.06.2026",
      "datetime": "14-Aug-2026",
      "details": "Results for the quarter ended 30.06.2026",
      "source": "BSE"
    },
    {
      "caption": "Results For The Quarter Ended 30.06.2026",
      "datetime": "14-Aug-2026",
      "details": "Results for the quarter ended 30.06.2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

12-Sep-2026 | Source : BSE

Resignation of Company Secretary & Compliance Officer

Board Meeting Outcome for Results For The Quarter Ended 30.06.2026

14-Aug-2026 | Source : BSE

Results for the quarter ended 30.06.2026

Results For The Quarter Ended 30.06.2026

14-Aug-2026 | Source : BSE

Results for the quarter ended 30.06.2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available